Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

DMACDMAC
Showing 8 of 28 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in DIAMEDICA THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 894,115 shares of DMAC (DIAMEDICA THERAPEUTICS INC), worth $6.3M as of 2026-Q2. The position was increased (+14.6% shares). DMAC represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$6.3M

Current Shares

894,115

Total Value Change

+$5M

Total Shares Change

+587,157

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
894,115
+14.6%
$6.3M0.0%$7.04
31
2026-Q1
Increased
780,516
+2.1%
$5.3M0.0%$7.71
28
2025-Q4
Increased
764,255
+7.4%
$6.1M0.0%$8.05
29
2025-Q3
Increased
711,818
+13.0%
$4.9M0.0%$6.91
30
2025-Q2
Increased
630,148
+99.6%
$2.5M0.0%$3.84
42
2025-Q1
Increased
315,741
+3.3%
$1.2M0.0%$3.82
26
2024-Q4
Decreased
305,751
-0.4%
$1.7M0.0%$5.34
0
2024-Q3
Increased
306,958
+29.6%
$1.3M0.0%$4.18
32

Other major holders of DMAC: COOPERMAN LEON G, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used